Nasopharyngeal Diseases  >>  ifosfamide  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ifosfamide / Generic mfg.
NCT00484601: Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

Terminated
2
9
RoW
Ifosfamide, Doxorubicin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Refractory Nasopharyngeal Carcinoma
11/07
11/07

Download Options